title: Mechanisms of bilirubin toxicity: clinical implications.
abstract: The basic mechanism of kernicterus and bilirubin encephalopathy has not been unequivocally determined. Much knowledge has been gained about phenomena that contribute to bilirubin neurotoxicity, and this knowledge has implications for clinical practice. Conditions that impact on blood-brain barrier function, increase brain blood flow, or impact on bilirubin metabolism, including its transport in serum, should be avoided, if possible. Such conditions include drugs and drug stabilizers that compete with bilirubin binding to albumin, or that inhibit P-glycoprotein in the blood-brain barrier, prematurity/immaturity, and clinically significant illness in the infant that involves hemolysis, respiratory and metabolic acidosis, infection, asphyxia, hypoxia and (perhaps) hyperoxia, and hyperosmolality. If these conditions are not avoidable then there should be a more aggressive approach to the treatment of hyperbilirubinemia. The limits of tolerance for hyperbilirubinemia varies among neonates and there are no tools to determine with certainty when a particular infant is approaching the danger zone. Neurological symptoms in a jaundiced infant require extreme vigilance, and, in most cases, immediate intervention.
authors.affiliation: Section on Neonatology, Department of Pediatrics, Rikshospitalet, University of Oslo, NO-0027 Oslo, Norway. t.w.r.hansen@klinmed.uio.no
authors.forename: Thor Willy Ruud
authors.initials: TW
authors.lastname: Hansen
mesh_terms: D001663:Bilirubin / Q000737:chemistry / Q000502:physiology; D001783:Blood Flow Velocity; D001812:Blood-Brain Barrier; D001923:Brain Chemistry; D002560:Cerebrovascular Circulation; D006801:Humans; D006932:Hyperbilirubinemia / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D007647:Kernicterus / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D011181:Postnatal Care / Q000379:methods / Q000592:standards; D017410:Practice Guidelines as Topic; D012307:Risk Factors
chemical_list: D001663:Bilirubin